FMT
BPMC

First Mercantile Trust’s Blueprint Medicines BPMC Stock Holding History

First Mercantile Trust’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$145K Buy
1,410
+281
+25% +$26.2K 0.02% 532
2021
Q2 		$99K Buy
+1,129
New +$103K 0.01% 685
2018
Q2 		– Sell
-2,338
Closed -$214K – 930
2018
Q1 		$214K Sell
2,338
-90
-4% -$7.76K 0.04% 475
2017
Q4 		$183K Buy
+2,428
New +$171K 0.04% 560

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

First Mercantile Trust's BPMC Position: Q3 2021 in Review

First Mercantile Trust increased its Blueprint Medicines (BPMC) stake by 25% in Q3 2021, buying an estimated $26.2K and bringing the position to 1,410 shares worth $145K. The position accounts for 0.02% of the portfolio, ranked #532.

First Mercantile Trust first reported a position in BPMC in Q4 2017 and has held it in 4 quarters since. The position peaked at $214K in Q1 2018. 288 funds tracked by Wall St. Rank hold BPMC as of Q3 2021.

  • First Mercantile Trust held 1,410 shares of Blueprint Medicines worth $145K as of Q3 2021.
  • First Mercantile Trust bought 281 Blueprint Medicines shares in Q3 2021, an estimated $26.2K.
  • Blueprint Medicines made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #532 holding.
  • First Mercantile Trust first reported a position in Blueprint Medicines in Q4 2017 and has held it in 4 quarters since.
  • First Mercantile Trust's Blueprint Medicines position peaked at $214K in Q1 2018.
  • 288 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.